Yinggu Xinye Capital

The firm operates three strategy lines: growth equity for late-stage private companies, PIPE deals for publicly listed companies seeking strategic minority investors, and general venture capital for earlier-stage positions. This multi-strategy design is unusual in China's private markets, where most managers specialize in a single stage or transaction type. The approach allows the firm to deploy capital on both sides of the IPO event.

The firm's investment activity is concentrated in China, with deal sourcing focused on Beijing, Shanghai, and the Greater Bay Area. There is no public record of offshore investment vehicles or cross-border deal flow. The domestic-only posture is consistent with many mid-market Chinese PE managers that operate within the onshore capital account framework.

No. The firm has not published an AUM figure in any public filing, press release, or regulatory disclosure. This is common among China-based private equity managers that do not raise capital from foreign institutional LPs, which typically require audited AUM reporting as a condition of commitment. The firm's AUM remains undisclosed as of the most recent available information.

The PIPE strategy provides a complementary deployment channel to the firm's growth and venture activities. By investing in publicly listed companies through private placements, the firm can access mature businesses that would not typically sell minority stakes to private equity. This creates a portfolio that spans the full corporate lifecycle — from unlisted ventures to mid-cap A-share and STAR Market companies — under a single investment mandate.

The firm's investment professionals and senior leadership are not identified in publicly available records. This is consistent with the low-disclosure posture of many Chinese private capital managers that do not market internationally or maintain English-language investor communications. No named principals could be confirmed through regulatory databases, press archives, or the firm's own materials.